P3 Health Partners (PIII) risk factors, FY2025 10-K

P3 Health Partners's FY2025 10-K, filed Mar 26, 2026, lists 86 risk factors in 7 groups. Against the prior year's 84: 4 new, 2 dropped, 60 substantially reworded.

Open PIII in Gloom →
P3 Health Partners' chart, financials and news, free in your browser.Open PIII in Gloom →
Risk factors listed
867 groups
New this year
4vs 84 last year
Dropped
2since the prior 10-K
Substantially reworded
60of those kept
Section length
27k wordsItem 1A

What the changes say

  • P3 Health Partners faces heightened regulatory scrutiny in California, ongoing solvency and compliance challenges, and emerging legal risks around AI technologies.

What changed since the prior 10-K

New

  • NewRisks Related to Our Business and Financial Results

    If our affiliated physician groups and Restricted Knox-Keene licensed health plans are not able to satisfy California regulations related to financial solvency and operational performance, they could become subject to sanctions, and their ability to do business in California could be limited or terminated

    Our affiliated physician groups and Restricted Knox-Keene health plans must maintain a 0.75 cash-to-claims ratio and comply with California DMHC solvency regulations or face sanctions and termination.

  • NewRisks Related to Our Business and Industry

    structure and premium competition. In addition, current and potential competitors have established, and may in the future establish, cooperative relationships with providers of complementary services, technologies or services to increase the attractiveness of their services

    New competitors and alliances with greater market share and financial resources could put us at a disadvantage and pressure payor premiums.

  • NewRisks Related to Our Business and Industry

    Changes in laws and regulations related to AI Technologies could adversely affect our products, services, and results of operations

    Evolving federal and state regulations regarding the use of AI technologies in healthcare applications could create compliance uncertainties and operational impacts.

  • NewRisks Related to Our Warrants

    otherwise wish to hold your Public Warrants or (iii) to accept the nominal redemption price which, at the time the outstanding Public Warrants are called for redemption, is likely to be substantially less than the market value of your Public Warrants

    We may redeem public warrants at $5.00 per share if our Class A common stock price equals or exceeds $500.00 per share.

Dropped

  • DroppedRisks Related to Our Business and Industry

    management of healthcare costs, which could produce results that are inconsistent with our estimates and financial models and negatively impact our growth

  • DroppedRisks Related to Our Business and Industry

    grow at the rates we have projected. We expect that competition will continue to increase as a result of consolidation in the healthcare industry and increased demand for its services

Reworded

  • 100% rewrittenRisks Related to Our Business and Financial Results

    P3 Health Partners Inc. | 2025 Form 10-K | 18

    Changed from going concern liquidity warnings to disclose that Medcore HP failed DMHC tangible net equity requirements and submitted a corrective action plan in March 2026.

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 17

  • 100% rewrittenRisks Related to Our Operating History

    P3 Health Partners Inc. | 2025 Form 10-K | 21

    Replaced credit facility covenant defaults and going concern audit disclosures with general descriptions of the operational dilutions and constraints of raising additional funding.

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 19

  • 100% rewrittenRisks Related to Our Business and Industry

    P3 Health Partners Inc. | 2025 Form 10-K | 23

    Replaced key employee recruitment and labor shortage disclosures with product performance, pricing, and infrastructure competition factors.

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 20

  • 100% rewrittenRisks Related to Our Business and Industry

    P3 Health Partners Inc. | 2025 Form 10-K | 25

    Replaced medical cost ratio prediction risks with political and fiscal uncertainties affecting telehealth funding and modalities.

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 22

  • 100% rewrittenRisks Related to Our Business and Industry

    P3 Health Partners Inc. | 2025 Form 10-K | 26

    Replaced a past $5.0 million contract settlement and copayment dispute disclosure with general capitation contract loss and clinical outcome risks.

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 23

  • 100% rewrittenRisks Related to Our Business and Industry

    P3 Health Partners Inc. | 2025 Form 10-K | 30

    Replaced information blocking and HTI-3 final rule compliance disclosures with potential legal claims, regulatory penalties, and notification requirements from cyberattacks.

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 27

  • 100% rewrittenRisks Related to Our Business and Industry

    P3 Health Partners Inc. | 2025 Form 10-K | 32

    Replaced FTC consumer privacy scrutiny disclosures with general political administration shifts affecting tax legislation and effective tax rates.

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 29

  • 100% rewrittenRisks Related to Our Business and Industry

    P3 Health Partners Inc. | 2025 Form 10-K | 34

    Replaced generic operating performance risk factors with specific compliance costs and reporting obligations regarding AI technologies.

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 31

  • 100% rewrittenRisks Related to Our Legal and Regulatory Environment

    P3 Health Partners Inc. | 2025 Form 10-K | 38

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 35

  • 100% rewrittenRisks Related to Our Legal and Regulatory Environment

    P3 Health Partners Inc. | 2025 Form 10-K | 39

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 36

  • 100% rewrittenRisks Related to Ownership of Our Common Stock

    P3 Health Partners Inc. | 2025 Form 10-K | 41

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 40

  • 100% rewrittenRisks Related to Ownership of Our Common Stock

    P3 Health Partners Inc. | 2025 Form 10-K | 42

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 42

  • 100% rewrittenRisks Related to Ownership of Our Common Stock

    P3 Health Partners Inc. | 2025 Form 10-K | 43

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 44

  • 100% rewrittenRisks Related to the Tax Receivable Agreement

    P3 Health Partners Inc. | 2025 Form 10-K | 47

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 46

  • 100% rewrittenRisks Related to the Tax Receivable Agreement

    P3 Health Partners Inc. | 2025 Form 10-K | 48

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 47

  • 100% rewrittenRisks Related to Our Business and Industry

    P3 Health Partners Inc. | 2025 Form 10-K | 31

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 28

  • 100% rewrittenRisks Related to Our Legal and Regulatory Environment

    P3 Health Partners Inc. | 2025 Form 10-K | 35

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 32

  • 100% rewrittenRisks Related to the Tax Receivable Agreement

    P3 Health Partners Inc. | 2025 Form 10-K | 49

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 48

  • 100% rewrittenRisks Related to Our Legal and Regulatory Environment

    P3 Health Partners Inc. | 2025 Form 10-K | 36

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 33

  • 99% rewrittenRisks Related to the Tax Receivable Agreement

    P3 Health Partners Inc. | 2025 Form 10-K | 46

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 45

  • 99% rewrittenRisks Related to Our Legal and Regulatory Environment

    P3 Health Partners Inc. | 2025 Form 10-K | 37

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 34

  • 99% rewrittenRisks Related to Our Business and Industry

    P3 Health Partners Inc. | 2025 Form 10-K | 24

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 21

  • 96% rewrittenRisks Related to the Tax Receivable Agreement

    Scrutiny of, and evolving expectations regarding, sustainability and environmental, social, and governance (“ESG”) matters could increase our costs, harm our reputation and adversely impact our financial results

  • 95% rewrittenRisks Related to Our Operating History

    We may need to raise additional capital to fund our existing operations or develop and commercialize new services or expand our operations

  • 94% rewrittenRisks Related to Ownership of Our Common Stock

    Our failure to meet the continued listing requirements of The Nasdaq Capital Market could result in a delisting of our securities

  • 92% rewrittenRisks Related to Our Legal and Regulatory Environment

    Regulatory proposals directed at containing or lowering the cost of healthcare, including ACO REACH, and our participation, voluntary or otherwise, in such proposed models, could impact our business, financial condition, cash flows and operations

    Was: Regulatory proposals directed at containing or lowering the cost of healthcare, including the Direct Contracting Model, and our participation, voluntary or otherwise, in such proposed models, could impact our business, financial condition, cash flows and operations

  • 91% rewrittenRisks Related to Our Legal and Regulatory Environment

    P3 Health Partners Inc. | 2025 Form 10-K | 40

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 38

  • 83% rewrittenRisks Related to Our Business and Industry

    We rely on our management team and key employees and our business, financial condition, cash flows and results of operations could be harmed if we are unable to retain qualified personnel

  • 75% rewrittenRisks Related to Our Business and Industry

    Changes in U.S. tax laws, and the adoption of tax reform policies or changes in tax legislation or policies in jurisdictions outside of the United States, could adversely affect our operating results and financial condition

  • 73% rewrittenRisks Related to the Tax Receivable Agreement

    In certain cases, payments under the Tax Receivable Agreement may be accelerated and/or significantly exceed the actual benefits, if any, we realize in respect of the tax attributes subject to the Tax Receivable Agreement

  • 72% rewrittenRisks Related to Our Operating History

    Our business and the markets in which we operate are rapidly evolving, which makes it difficult to evaluate our future prospects and the risks and challenges we may encounter

  • 72% rewrittenRisks Related to the Tax Receivable Agreement

    Because we have no current plans to pay cash dividends on our Class A common stock for the foreseeable future, you may not receive any return on investment unless you sell your Class A common stock for a price greater than that which you paid for it

  • 70% rewrittenRisks Related to the Tax Receivable Agreement

    Our sole material asset is our interest in P3 LLC, and, accordingly, we depend on distributions from P3 LLC to pay our taxes and expenses, including payments under the Tax Receivable Agreement. P3 LLC’s ability to make such distributions may be subject to various limitations and restrictions

  • 63% rewrittenRisks Related to Our Warrants

    We may redeem unexpired Public Warrants prior to their exercise at a time that is disadvantageous to our stockholders, thereby making the Public Warrants worthless to our stockholders

  • 63% rewrittenRisks Related to Our Legal and Regulatory Environment

    We face inspections, reviews, audits and investigations under federal and state government programs and contracts. These audits could have adverse findings that may negatively affect our business, including our results of operations, liquidity, financial condition and reputation

  • 62% rewrittenRisks Related to Our Operating History

    We may not be able to maintain compliance with our debt covenants in the future which could result in an event of default

  • 58% rewrittenRisks Related to Our Business and Industry

    If we or our affiliated professional entities or other physician partners fail to comply with applicable data interoperability and information blocking rules, our consolidated results of operations could be adversely affected

  • 56% rewrittenRisks Related to Our Operating History

    P3 Health Partners Inc. | 2025 Form 10-K | 19

    Was: P3 Health Partners Inc. | 2024 Form 10-K | 18

  • 52% rewrittenRisks Related to Our Business and Industry

    Developments affecting spending by the healthcare industry could adversely affect our business

  • 51% rewrittenRisks Related to Our Business and Industry

    We primarily depend on reimbursement by third-party payors, as well as payments by individuals, which could lead to delays, uncertainties and disagreements regarding the timing and process of reimbursement, including any changes or reductions in Medicare reimbursement rates or rules

  • 48% rewrittenRisks Related to Our Business and Industry

    Any of these consequences could lower retention rate and have a material adverse effect on our business, financial condition and results of operations

  • 48% rewrittenRisks Related to the Tax Receivable Agreement

    We will be required to make payments under the Tax Receivable Agreement for certain tax benefits we may claim, and the amounts of such payments could be significant

  • 47% rewrittenRisks Related to Our Business and Industry

    Our quarterly results may fluctuate significantly, which could adversely impact the value of our Class A common stock and publicly traded warrants

  • 47% rewrittenRisks Related to Our Legal and Regulatory Environment

    The impact of recent healthcare legislation and other changes in the healthcare industry and in healthcare spending is currently unknown, but may adversely affect our business, financial condition and results of operations

  • 46% rewrittenRisks Related to Our Business and Industry

    We are dependent on our affiliated professional entities and other physician partners and other providers to effectively manage the quality and cost of care and perform obligations under payor contracts

  • 43% rewrittenRisks Related to Our Business and Industry

    Our growth depends in part on our ability to identify and develop successful new geographies, physician partners, payors and patients. If we are not able to successfully execute upon our growth strategies, there may be a material adverse effect on our business, financial condition, cash flows and results of operations

  • 41% rewrittenRisks Related to Our Business and Industry

    The termination or non-renewal of the Medicare Advantage contracts held by the health plans with which we contract, or the termination or nonrenewal of our contracts with those plans, could have a material adverse effect on our revenue and operations

  • 41% rewrittenRisks Related to Our Business and Industry

    We operate in a competitive industry, and if we are not able to compete effectively, our business, financial condition and results of operations will be harmed

  • 40% rewrittenRisks Related to the Tax Receivable Agreement

    Certain of the P3 Equityholders may receive payments under the Tax Receivable Agreement, and their interests may conflict with yours

  • 34% rewrittenRisks Related to Our Business and Industry

    Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards and other requirements could adversely affect our business, financial condition and results of operations

  • 33% rewrittenRisks Related to Our Business and Industry

    Our business could be adversely impacted by climate change, extreme weather conditions and natural disasters

  • 32% rewrittenRisks Related to Our Business and Industry

    Reductions in the quality ratings of the health plans we serve could have a material adverse effect on our business, results of operations, financial condition and cash flows

  • 31% rewrittenRisks Related to the Tax Receivable Agreement

    The market price and trading volume of our Class A common stock and Public Warrants may be volatile and could decline significantly

  • 30% rewrittenRisks Related to Our Warrants

    Our warrants may have an adverse effect on the market price of our Class A common stock

  • 27% rewrittenRisks Related to Our Business and Financial Results

    Our management has performed an analysis of our ability to continue as a going concern and has identified substantial doubt about our ability to continue as a going concern

  • 25% rewrittenRisks Related to Our Business and Industry

    We and our affiliated professional entities and other physician partners may become subject to medical liability claims, which could cause us to incur significant expenses and may require us to pay significant damages if the claims are not covered by insurance

  • 24% rewrittenRisks Related to Our Business and Industry

    Pandemics or epidemics have impacted, and may in the future impact, our operations and may materially and adversely affect our business and financial results

  • 23% rewrittenRisks Related to Ownership of Our Common Stock

    We cannot predict the impact our dual-class structure may have on the stock price of our Class A common stock

  • 21% rewrittenRisks Related to Our Operating History

    A significant portion of our assets consists of other intangible assets, the value of which may be reduced if we determine that those assets are impaired

  • 20% rewrittenRisks Related to Our Legal and Regulatory Environment

    Our records and submissions to a health plan may contain inaccurate or unsupportable information regarding risk adjustment scores of members, which could cause us to overstate or understate our revenue and subject us to various penalties

All 86 risk factors

Headings as the filing states them, in filing order.

Risks Related to Our Business and Financial Results

  1. 01Our management has performed an analysis of our ability to continue as a going concern and has identified substantial doubt about our ability to continue as a going concern27% rewritten
  2. 02If our affiliated physician groups and Restricted Knox-Keene licensed health plans are not able to satisfy California regulations related to financial solvency and operational performance, they could become subject to sanctions, and their ability to do business in California could be limited or terminatedNew
  3. 03P3 Health Partners Inc. | 2025 Form 10-K | 18100% rewritten

Risks Related to Our Operating History

  1. 04We have a history of net losses. We expect to continue to incur losses for the foreseeable future and we may never achieve or maintain profitability
  2. 05Our business and the markets in which we operate are rapidly evolving, which makes it difficult to evaluate our future prospects and the risks and challenges we may encounter72% rewritten
  3. 06P3 Health Partners Inc. | 2025 Form 10-K | 1956% rewritten
  4. 07Our relatively limited operating history makes it difficult to evaluate our future prospects and the risks and challenges we may encounter
  5. 08We may not be able to maintain compliance with our debt covenants in the future which could result in an event of default62% rewritten
  6. 09We may not recognize the anticipated benefits of recent and future acquisitions or dispositions and any such transactions could disrupt our operations and have a material adverse effect on our business, financial condition and results of operations
  7. 10A significant portion of our assets consists of other intangible assets, the value of which may be reduced if we determine that those assets are impaired21% rewritten
  8. 11We may need to raise additional capital to fund our existing operations or develop and commercialize new services or expand our operations95% rewritten
  9. 12P3 Health Partners Inc. | 2025 Form 10-K | 21100% rewritten

Risks Related to Our Business and Industry

  1. 13Pandemics or epidemics have impacted, and may in the future impact, our operations and may materially and adversely affect our business and financial results24% rewritten
  2. 14We rely on our management team and key employees and our business, financial condition, cash flows and results of operations could be harmed if we are unable to retain qualified personnel83% rewritten
  3. 15Our growth depends in part on our ability to identify and develop successful new geographies, physician partners, payors and patients. If we are not able to successfully execute upon our growth strategies, there may be a material adverse effect on our business, financial condition, cash flows and results of operations43% rewritten
  4. 16P3 Health Partners Inc. | 2025 Form 10-K | 23100% rewritten
  5. 17Any of these consequences could lower retention rate and have a material adverse effect on our business, financial condition and results of operations48% rewritten
  6. 18P3 Health Partners Inc. | 2025 Form 10-K | 2499% rewritten
  7. 19We primarily depend on reimbursement by third-party payors, as well as payments by individuals, which could lead to delays, uncertainties and disagreements regarding the timing and process of reimbursement, including any changes or reductions in Medicare reimbursement rates or rules51% rewritten
  8. 20P3 Health Partners Inc. | 2025 Form 10-K | 25100% rewritten
  9. 21The termination or non-renewal of the Medicare Advantage contracts held by the health plans with which we contract, or the termination or nonrenewal of our contracts with those plans, could have a material adverse effect on our revenue and operations41% rewritten
  10. 22We are dependent on our affiliated professional entities and other physician partners and other providers to effectively manage the quality and cost of care and perform obligations under payor contracts46% rewritten
  11. 23P3 Health Partners Inc. | 2025 Form 10-K | 26100% rewritten
  12. 24Reductions in the quality ratings of the health plans we serve could have a material adverse effect on our business, results of operations, financial condition and cash flows32% rewritten
  13. 25We operate in a competitive industry, and if we are not able to compete effectively, our business, financial condition and results of operations will be harmed41% rewritten
  14. 26structure and premium competition. In addition, current and potential competitors have established, and may in the future establish, cooperative relationships with providers of complementary services, technologies or services to increase the attractiveness of their servicesNew
  15. 27Our future growth and the success of our business will depend in large part upon the effectiveness and efficiency of our marketing efforts, and our ability to develop brand awareness cost-effectively
  16. 28Developments affecting spending by the healthcare industry could adversely affect our business52% rewritten
  17. 29P3 Health Partners Inc. | 2025 Form 10-K | 28
  18. 30We and our affiliated professional entities and other physician partners may become subject to medical liability claims, which could cause us to incur significant expenses and may require us to pay significant damages if the claims are not covered by insurance25% rewritten
  19. 31If we or our affiliated professional entities or other physician partners fail to comply with applicable data interoperability and information blocking rules, our consolidated results of operations could be adversely affected58% rewritten
  20. 32Our business and operations would suffer in the event of information technology system failures, security breaches, cyberattacks or other deficiencies in cybersecurity
  21. 33P3 Health Partners Inc. | 2025 Form 10-K | 30100% rewritten
  22. 34Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards and other requirements could adversely affect our business, financial condition and results of operations34% rewritten
  23. 35P3 Health Partners Inc. | 2025 Form 10-K | 31100% rewritten
  24. 36Any future litigation against us could be costly and time-consuming to defend
  25. 37Changes in U.S. tax laws, and the adoption of tax reform policies or changes in tax legislation or policies in jurisdictions outside of the United States, could adversely affect our operating results and financial condition75% rewritten
  26. 38P3 Health Partners Inc. | 2025 Form 10-K | 32100% rewritten
  27. 39Our quarterly results may fluctuate significantly, which could adversely impact the value of our Class A common stock and publicly traded warrants47% rewritten
  28. 40Our only significant asset is the ownership of a minority of the economic interest in P3 LLC, and such ownership may not be sufficient to generate the funds necessary to meet our financial obligations or to pay any dividends on our Class A common stock
  29. 41Our business could be adversely impacted by climate change, extreme weather conditions and natural disasters33% rewritten
  30. 42Changes in laws and regulations related to AI Technologies could adversely affect our products, services, and results of operationsNew
  31. 43P3 Health Partners Inc. | 2025 Form 10-K | 34100% rewritten

Risks Related to Our Legal and Regulatory Environment

  1. 44P3 Health Partners Inc. | 2025 Form 10-K | 35100% rewritten
  2. 45P3 Health Partners Inc. | 2025 Form 10-K | 36100% rewritten
  3. 46If our arrangements with our affiliated professional entities and other physician partners are found to constitute the improper rendering of medical services or fee splitting under applicable state laws, our business, financial condition and our ability to operate in those states could be adversely impacted
  4. 47We face inspections, reviews, audits and investigations under federal and state government programs and contracts. These audits could have adverse findings that may negatively affect our business, including our results of operations, liquidity, financial condition and reputation63% rewritten
  5. 48P3 Health Partners Inc. | 2025 Form 10-K | 3799% rewritten
  6. 49Our records and submissions to a health plan may contain inaccurate or unsupportable information regarding risk adjustment scores of members, which could cause us to overstate or understate our revenue and subject us to various penalties20% rewritten
  7. 50P3 Health Partners Inc. | 2025 Form 10-K | 38100% rewritten
  8. 51The impact of recent healthcare legislation and other changes in the healthcare industry and in healthcare spending is currently unknown, but may adversely affect our business, financial condition and results of operations47% rewritten
  9. 52P3 Health Partners Inc. | 2025 Form 10-K | 39100% rewritten
  10. 53The evolving regulation of value-based reimbursement models and regulation, licensure and oversight by state regulatory authorities as a risk-bearing entity may have a material adverse effect on our operations
  11. 54Regulatory proposals directed at containing or lowering the cost of healthcare, including ACO REACH, and our participation, voluntary or otherwise, in such proposed models, could impact our business, financial condition, cash flows and operations92% rewritten
  12. 55P3 Health Partners Inc. | 2025 Form 10-K | 4091% rewritten

Risks Related to Ownership of Our Common Stock

  1. 56Our failure to meet the continued listing requirements of The Nasdaq Capital Market could result in a delisting of our securities94% rewritten
  2. 57P3 Health Partners Inc. | 2025 Form 10-K | 41100% rewritten
  3. 58We cannot predict the impact our dual-class structure may have on the stock price of our Class A common stock23% rewritten
  4. 59P3 Health Partners Inc. | 2025 Form 10-K | 42100% rewritten
  5. 60Delaware law and our certificate of incorporation and bylaws contain certain provisions, including anti-takeover provisions that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable
  6. 61These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our board of directors or management
  7. 62P3 Health Partners Inc. | 2025 Form 10-K | 43100% rewritten
  8. 63The provision of our certificate of incorporation requiring exclusive forum in certain courts in the State of Delaware or the federal district courts of the United States for certain types of lawsuits may have the effect of discouraging lawsuits against our directors and officers
  9. 64Additionally, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act
  10. 65An active, liquid trading market for our Class A common stock may not be sustained
  11. 66There may be sales of a substantial amount of our Class A common stock in future by our stockholders, and these sales could cause the price of our Class A common stock to fall

Risks Related to Our Warrants

  1. 67Our warrants may have an adverse effect on the market price of our Class A common stock30% rewritten
  2. 68We may redeem unexpired Public Warrants prior to their exercise at a time that is disadvantageous to our stockholders, thereby making the Public Warrants worthless to our stockholders63% rewritten
  3. 69otherwise wish to hold your Public Warrants or (iii) to accept the nominal redemption price which, at the time the outstanding Public Warrants are called for redemption, is likely to be substantially less than the market value of your Public WarrantsNew
  4. 70Certain of our warrants are accounted for as liabilities and the changes in value of these warrants could have a material effect on our financial results

Risks Related to the Tax Receivable Agreement

  1. 71Our sole material asset is our interest in P3 LLC, and, accordingly, we depend on distributions from P3 LLC to pay our taxes and expenses, including payments under the Tax Receivable Agreement. P3 LLC’s ability to make such distributions may be subject to various limitations and restrictions70% rewritten
  2. 72P3 Health Partners Inc. | 2025 Form 10-K | 4699% rewritten
  3. 73We will be required to make payments under the Tax Receivable Agreement for certain tax benefits we may claim, and the amounts of such payments could be significant48% rewritten
  4. 74P3 Health Partners Inc. | 2025 Form 10-K | 47100% rewritten
  5. 75In certain cases, payments under the Tax Receivable Agreement may be accelerated and/or significantly exceed the actual benefits, if any, we realize in respect of the tax attributes subject to the Tax Receivable Agreement73% rewritten
  6. 76We will not be reimbursed for any payments made to P3 Equityholders under the Tax Receivable Agreement in the event that any tax benefits are disallowed
  7. 77Certain of the P3 Equityholders may receive payments under the Tax Receivable Agreement, and their interests may conflict with yours40% rewritten
  8. 78P3 Health Partners Inc. | 2025 Form 10-K | 48100% rewritten
  9. 79We may be subject to securities litigation, which is expensive and could divert management attention
  10. 80Because we have no current plans to pay cash dividends on our Class A common stock for the foreseeable future, you may not receive any return on investment unless you sell your Class A common stock for a price greater than that which you paid for it72% rewritten
  11. 81The market price and trading volume of our Class A common stock and Public Warrants may be volatile and could decline significantly31% rewritten
  12. 82P3 Health Partners Inc. | 2025 Form 10-K | 49100% rewritten
  13. 83If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, the price and trading volume of our securities could decline
  14. 84We will continue to incur significantly increased costs and devote substantial management time as a result of operating as a public company
  15. 85Our results of operations and financial condition are subject to management’s accounting judgments and estimates, as well as changes in accounting policies
  16. 86Scrutiny of, and evolving expectations regarding, sustainability and environmental, social, and governance (“ESG”) matters could increase our costs, harm our reputation and adversely impact our financial results96% rewritten

Other P3 Health Partners 10-Ks

  • FY2024 10-K risk factors
    84 risks

    Substantial doubt about going concern due to $38.8M unrestricted cash, $154.8M debt, and $310.4M net losses in 2024.

    Filed Mar 28, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.